发明名称 PHARMACEUTICAL COMPOSITIONS
摘要 FIELD: medicine, pharmaceutics. ^ SUBSTANCE: invention concerns valsartan pill obtained by pressing. A pill contains pharmacologically effective valsartan quantity, filler and fluffer. Weight ratio of valsartan to filler is 2:1 to 0.3:1. Weight ratio of valsartan to fluffer is 2.9:1 to 1:1. The pill includes over 30 mass % of filler. Preferable filler is monocrystallic cellulose. Preferable fluffer is crospovidone. The claimed pill has at least 1.2 times higher biological accessibility in comparison to the known valsartan-containing composition. ^ EFFECT: increased biological accessibility of valsartan-containing composition. ^ 9 cl, 2 dwg, 4 tbl, 8 ex
申请公布号 RU2333757(C2) 申请公布日期 2008.09.20
申请号 RU20030100507 申请日期 2001.06.20
申请人 NOVARTIS AG 发明人 GANTER ZABINA MARIJA;VAGNER ROBERT FREHNK
分类号 A61K9/16;A61K31/41;A61K9/20;A61P9/04;A61P9/12;A61P43/00 主分类号 A61K9/16
代理机构 代理人
主权项
地址